Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Non-Tubercular Mycobacteria
Have you had success treating localized skin infections due to M. chelonae with single agent therapy in immunocompetent hosts?
Related Questions
How long would you continue intravenous suppressive therapy following surgical washout for a patient with an LVAD as destination therapy, found to have an outflow tract fluid collection secondary to fluoroquinolone-resistant pseudomonas aeruginosa?
How would you manage a patient with necrotizing pneumonia due to a susceptible Pseudomonas aeruginosa strain who continues to have significant purulent secretions and worsening imaging while receiving cefepime?
What factors do you consider when choosing between baloxavir and oseltamivir for treating patients with influenza?
What is your preferred laboratory test to assess treatment response or infection resolution in patients with bacterial pneumonia?
Would you recommend antifungal treatment or observation without therapy in an immunocompetent patient with a pulmonary nodule who underwent malignancy workup and was found to have yeast forms consistent with histoplasma on GMS stain?
How do you approach a persistently positive Mycoplasma genitalium cervical swab PCR in a patient who has undergone multiple courses of the standard CDC-recommended therapy but continues to experience pelvic symptoms and vaginal discharge?
Under what circumstance would you order dalbavancin instead of vancomycin or daptomycin for MRSA endocarditis?
How would you manage a patient with brucella melitensis abscess in whom surgery was initially deferred, developed worsening lower extremity numbness and weakness and MRI findings despite 1 month of combination therapy with ceftriaxone, rifampin, and doxycycline, and who is now readmitted to hospital following surgical washout?
What criteria should be used to determine the timing of placing central venous access or cardiac devices in patients with Staphylococcus lugdunensis infective endocarditis, considering the skip phenomenon?
Is there a specific criteria that you use to determine if a patient with respiratory symptoms should have a multiplex respiratory test performed?
